載入...
Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
Second mitochondrial activator of caspase (Smac)-mimetic compounds and oncolytic viruses were developed to kill cancer cells directly. However, Smac-mimetic compound and oncolytic virus therapies also modulate host immune responses in ways we hypothesized would complement one another in promoting an...
Na minha lista:
| 發表在: | Nat Commun |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5570934/ https://ncbi.nlm.nih.gov/pubmed/28839138 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41467-017-00324-x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|